BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 26355024)

  • 1. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
    Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
    J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
    Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model.
    Zandi M; Dehghan A; Malekzadeh H; Janbaz P; Ghadermazi K; Amini P
    J Craniomaxillofac Surg; 2016 Mar; 44(3):271-8. PubMed ID: 26805920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Shudo A; Kishimoto H; Takaoka K; Noguchi K
    Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy.
    Hasegawa T; Ri S; Umeda M; Komatsubara H; Kobayashi M; Shigeta T; Yoshitomi I; Ikeda H; Shibuya Y; Asahina I; Komori T
    J Craniomaxillofac Surg; 2013 Oct; 41(7):558-63. PubMed ID: 23332469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
    Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
    Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats.
    Zandi M; Dehghan A; Mohammadi-Mofrad A; Amini P; Vahdatinia F
    J Craniomaxillofac Surg; 2017 Feb; 45(2):275-280. PubMed ID: 28087282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
    Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
    J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
    Marino KL; Zakhary I; Abdelsayed RA; Carter JA; O'Neill JC; Khashaba RM; Elsalanty M; Stevens MR; Borke JL
    J Oral Implantol; 2012 Sep; 38 Spec No():511-8. PubMed ID: 21905888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study.
    Oliveira CC; Barros Silva PG; Ferreira AEC; Gonçalves RP; Sousa FB; Mota MRL; Alves APNN
    Arch Oral Biol; 2017 Nov; 83():317-326. PubMed ID: 28869827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further development of the MRONJ minipig large animal model.
    Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep.
    Voss PJ; Stoddart MJ; Bernstein A; Schmelzeisen R; Nelson K; Stadelmann V; Ziebart T; Poxleitner PJ
    Clin Oral Investig; 2016 Jan; 20(1):31-8. PubMed ID: 25843053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronate induces osteonecrosis of the jaw in sheep.
    Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study.
    Dayisoylu EH; Şenel FÇ; Üngör C; Tosun E; Çankaya M; Ersöz S; Taskesen F
    Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1475-80. PubMed ID: 23746422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial profile and bone healing in rats receiving cancer therapeutic doses of bisphosphonates and corticosteroids: a pilot study.
    Jabbour Z; do Nascimento C; El-Hakim M; Henderson JE; de Albuquerque Junior RF
    Int J Oral Maxillofac Surg; 2016 Sep; 45(9):1162-9. PubMed ID: 26780925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.
    Agaçayak KS; Yuksel H; Atilgan S; Koparal M; Uçan MC; Ozgöz M; Yaman F; Atalay Y; Acikan I
    Niger J Clin Pract; 2014; 17(5):559-64. PubMed ID: 25244263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws.
    Koneski F; Popovic-Monevska D; Gjorgoski I; Krajoska J; Popovska M; Muratovska I; Velickovski B; Petrushevska G; Popovski V
    J Craniomaxillofac Surg; 2018 Feb; 46(2):230-236. PubMed ID: 29233701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.